AbbVie, after losing Humira trade secrets theft case, eyes new strategy in Alvotech fight fkansteiner Tue, 12/21/2021 – […]
Acadia slims Nuplazid label expansion bid in hopes of clinching Alzheimer’s dementia nod without extra studies fkansteiner Tue, […]
Scientists at the Universidad Carlos III de Madrid have developed the first photo-electrochemical aptasensor that detects the SARS-CoV-2 […]
Reliable and feasible early detection of Alzheimer’s disease is the goal of DEBBIE, an international joint project under […]
AbstractObjectiveTo evaluate pathological complete response as a surrogate endpoint for disease-free survival and overall survival in regulatory neoadjuvant […]
In 2017, we described the previous UK drug strategy as full of “false claims and empty promises.”1 The […]
AbstractObjectiveTo estimate the association between untreated, community acquired, respiratory tract infections and bleeding in oral anticoagulant users.DesignSelf-controlled case…
With approval, Saphnelo would be the first available treatment for systematic lupus erythematosus in Europe in over ten […]
The DETERMINE trial aims to discover whether existing ‘licensed’ drugs could also benefit patients with rare cancer types […]
It was a step too far for ninety nine Conservative MPs. They were simply unwilling to support the […]